TABLE 1.
Method | Measure | Domain assessed | V1 | V2 | M |
Clinical interview: | K-SADS-PL | Clinical diagnosis | X | ||
CDRS-R | Depression symptom severity | X | |||
C-SSR-S | Suicidal ideation and behaviors | X | |||
SITBI | Non-suicidal self-injury | X | |||
FIGS* | Family psychiatric history | X | |||
Self-report: | Tanner | Pubertal development | X | ||
RADS-2 | Depression symptom severity | X | X | ||
SIQ-JH | Explicit suicidal ideation | X | |||
PHQ-9 | Depression symptom severity | X | X | ||
MASC-2 | Anxiety symptom severity | X | X | ||
MPVS | Bullying | X | |||
STRAIN | Life stress | X | |||
CTQ* | Childhood trauma | X | |||
DERS* | Emotion regulation difficulties | X | |||
MRI: | T1-weighted SPGR | Grey and white matter | X | ||
Resting-state fMRI | Functional connectivity | X | |||
Diffusion-weighted MRI | Structural connectivity | X | |||
1H-MRS (ACC) | Glutamate, Glutathione, Ascorbate | X | |||
ACC Glu | Glutamate | X | |||
ACC GSH and ACC Asc | Antioxidants | X | |||
Cognitive task: | IAT – death version | Implicit suicidal ideation | X | ||
Blood: | IL-1β, IL-6, IL-10, TNF-α | Inflammation | X |
Measures will be assessed at all three timepoints unless marked with a * which indicates the measure will only be administered at T1. Measures under column “M” are administered at the bi-monthly online follow-up assessments.